Ark Biosciences Funding: $230M Raised, Series A (2015)
Ark Biosciences is based in Shanghai, China. It has raised $230M in total funding. Latest round: Series A.
Ark Biosciences funding overview
Ark Biosciences is based in Shanghai, China. Ark Biosciences has raised $230M in total disclosed funding. That places its disclosed total in the $100M–$250M range. Its most recent disclosed round is a Series A announced in April 2015. The round record for Ark Biosciences runs through 2015; nothing later has been disclosed. Investors on record include TPG, Decheng Capital, Loayal Valley Capital, Qiming Venture Partners, Morningside Venture, TF Capital. 6 distinct backers are named across the disclosed rounds.
Ark Biosciences at a glance
Total raised
$230M
Latest round
Series A
Latest round date
April 2015
Headquarters
Shanghai, China
Notable investors
TPG, Decheng Capital, Loayal Valley Capital, Qiming Venture Partners, Morningside Venture, TF Capital
Frequently asked about Ark Biosciences funding
How much has Ark Biosciences raised?
Ark Biosciences has raised $230M in total disclosed funding across the rounds on record.
Who has invested in Ark Biosciences?
TPG, Decheng Capital, Loayal Valley Capital, Qiming Venture Partners, Morningside Venture, TF Capital are named among the investors backing Ark Biosciences.
What was the latest Ark Biosciences funding round?
The most recent disclosed round is a Series A, announced in April 2015.
Where is Ark Biosciences based?
Ark Biosciences is based in Shanghai, China.
When did Ark Biosciences last raise?
The last disclosed Ark Biosciences round closed in April 2015 at Series A.
Totals shown for Ark Biosciences aggregate every disclosed round on file. To see how that compares, browse the companies in Shanghai and the investors behind them below.
